ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

23,822Medicare Part D Prescriptions Filled, Including Refills

Rank: 42 out of 780

$1.13M Total Retail Price of All Prescriptions

Rank: 46 out of 780

1,049 Patients Receiving at Least One Drug in Part D
77%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Alabama
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 1,049 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 1,049 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

2% of this provider’s 18,682 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 23.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Alabama
FUROSEMIDE 819 688 1 7
LEVOTHYROXINE SODIUM 749 648 2 5
AMLODIPINE BESYLATE 633 533 3 4
LISINOPRIL 633 508 3 6
PRAVASTATIN SODIUM 614 484 5 9
SIMVASTATIN 595 503 6 2
HYDROCHLOROTHIAZIDE 539 448 7 10
HYDROCODONE-ACETAMINOPHEN 508 343 S3 8 1
ATORVASTATIN CALCIUM 470 371 9 12
ATENOLOL 469 390 10 21
WARFARIN SODIUM 467 328 11 24
POTASSIUM CHLORIDE 451 389 12 11
METFORMIN HCL 436 359 13 8
OMEPRAZOLE 434 330 14 3
DONEPEZIL HCL 402 380 15 31
CARVEDILOL 369 321 16 14
METOPROLOL TARTRATE 367 297 17 19
SERTRALINE HCL 349 251 18 27
LISINOPRIL-HYDROCHLOROTHIAZIDE 296 210 19 26
GLIPIZIDE 260 229 20 74
NAMENDA 249 217 21 46
ALLOPURINOL 248 219 22 29
LANTUS 241 188 23 71
TRAZODONE HCL 226 118 24 35
GABAPENTIN 225 187 25 13
TAMSULOSIN HCL 222 204 26 36
CLONIDINE HCL 219 171 27 28
NAPROXEN 189 139 28 100
POLYETHYLENE GLYCOL 3350 187 140 29 79
AZITHROMYCIN 180 141 30 38
ENALAPRIL MALEATE 178 138 31 64
CYCLOBENZAPRINE HCL 173 123 R 32 42
HYDRALAZINE HCL 169 146 33 54
GEMFIBROZIL 167 132 34 104
ADVAIR DISKUS 162 134 35 68
QUETIAPINE FUMARATE 162 125 35 81
CYMBALTA 147 130 37 51
ESCITALOPRAM OXALATE 137 101 38 61
PANTOPRAZOLE SODIUM 134 108 39 25
TRIAMTERENE-HCTZ 132 104 40 37
CHLORTHALIDONE 130 117 41 142
ZOLPIDEM TARTRATE 128 83 42 17
JANUVIA 126 103 43 85
CRESTOR 125 123 44 32
PREDNISONE 124 91 45 40
MIRTAZAPINE 124 97 45 58
METOPROLOL SUCCINATE 123 103 47 20
LOSARTAN POTASSIUM 121 99 48 18
HUMULIN 70-30 120 94 49 106
CLOPIDOGREL 116 112 50 34
NEXIUM 114 94 51 22
LOVASTATIN 110 86 52 47
INSULIN SYRINGE 110 70 52 80
OXYCODONE-ACETAMINOPHEN 109 84 S2 54 187
METOLAZONE 109 88 54 195
LEVETIRACETAM 108 70 56 130
TRAMADOL HCL-ACETAMINOPHEN 106 90 57 140
RISPERIDONE 106 60 57 98
CITALOPRAM HBR 104 71 59 23
DIOVAN 98 88 60 55
KLOR-CON 10 98 90 60 90
MELOXICAM 96 63 62 16
SPIRIVA 95 87 63 72
KLOR-CON M20 93 66 64 57
HUMALOG 92 80 65 192
METFORMIN HCL ER 92 63 65 43
DIGOXIN 91 84 67 56
TRAMADOL HCL 90 63 68 15
PLAVIX 85 81 69 45
PROMETHAZINE HCL 84 58 R 70 66
SPIRONOLACTONE 82 57 71 53
GLIPIZIDE ER 82 76 71 109
CLOTRIMAZOLE-BETAMETHASONE 81 76 73 166
NOVOLOG 80 55 74 158
DIVALPROEX SODIUM 78 63 75 119
CIPROFLOXACIN HCL 78 55 75 49
VERAPAMIL ER 77 71 77 78
VENLAFAXINE HCL 74 59 78 226
PAROXETINE HCL 73 37 79 69
TERAZOSIN HCL 73 71 79 160
AMIODARONE HCL 73 73 79 139
NYSTATIN 72 65 82 203
CARBIDOPA-LEVODOPA 71 58 83 124
ALENDRONATE SODIUM 71 43 83 44
METOCLOPRAMIDE HCL 69 58 85 102
GENERLAC 69 40 85 246
RANITIDINE HCL 68 40 87 39
PHENYTOIN SODIUM EXTENDED 67 34 88 128
LEVEMIR 66 63 89 198
DOXAZOSIN MESYLATE 66 58 89 97
HUMULIN N 65 65 91 320
MECLIZINE HCL 64 60 92 83
SULINDAC 63 52 93 268
CEPHALEXIN 63 41 93 105
LYRICA 62 46 95 52
COLCRYS 61 43 96 131
FLUOXETINE HCL 58 45 97 65
TOPIRAMATE 58 26 97 145
TRIAMCINOLONE ACETONIDE 57 38 99 154
AMITRIPTYLINE HCL 56 39 R 100 48
LACTULOSE 56 33 100 178
ISOSORBIDE MONONITRATE ER 54 48 102 60
NIASPAN 54 22 102 167
DILTIAZEM 24HR CD 53 52 104 138
LOSARTAN-HYDROCHLOROTHIAZIDE 53 49 104 33
ESTRADIOL 52 40 R 106 122
NOVOLIN 70-30 52 36 106 164
CARBAMAZEPINE 51 26 108 257
DIOVAN HCT 50 50 109 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 12, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.